Current filters:

BiosimilarsMen's Health

1 to 9 of 95961 results

Novartis' investigational heart failure drug LCZ696 shows striking efficacy


Swiss drug major Novartis on Saturday presented striking new data for its LZC696 heart drug at the European…


United Thera scores over Sandoz in Remodulin patent case


US biotech company United Therapeutics’ shares leapt 28.5% to $117.83 on Friday, after the company…

GenericsLegalNovartisPatentsRemodulinRespiratory and PulmonarySandozUnited TherapeuticsUSA

Positive results from four pivotal alirocumab trials at ESC Congress


French pharma major Sanofi and US partner Regeneron Pharmaceuticals have announced detailed positive…

alirocumabBiotechnologyCardio-vascularRegeneron PharmaceuticalsResearchSanofi

Takeda and Lilly fail to overturn $9 billion award for hiding cancer risk of Actos


Japan’s largest drugmaker Takeda Pharmaceutical and US pharma major Eli Lilly have failed in their…

ActosDiabetesEli LillyFinancialLegalPharmaceuticalTakeda PharmaceuticalUSA

New studies planned to further expand indications for Xarelto


German pharma major Bayer and partner Janssen Research & Development, a unit of US health care giant…

BayerCardio-vascularJanssenJohnson & JohnsonPharmaceuticalResearchXarelto

FTC puts conditions on acquisition of Insight Pharma by Prestige Brands


US firm Prestige Brands Holdings, the maker of Dramamine (dimenhydrinate), has agreed to divest assets…

Insight PharmaceuticalsMergers & AcquisitionsPharmaceuticalPrestige BrandsRegulationUSA

Ipsen posts strong earnings growth for first-half 2014


French drugmaker Ipsen has reported first half 2014 sales of 638.7 million euros ($845.1 million), up…


1 to 9 of 95961 results

Back to top